CURRENT SHARE PRICE

LSE 49.50p NASDAQ $8.95

Updated every 15mins | Legal Disclaimer

Protherics Logo
  • HOME
  • COMPANY
    • BUSINESS FOCUS
    • OPERATIONS
    • DIRECTORS & MANAGEMENT
    • COMPANY MILESTONES
    • ADVISERS
    • ETHICS
    • GOVERNANCE
  • PRODUCTS
    • PRODUCTS SUMMARY
    • CRITICAL CARE
    • CANCER
    • OTHER PRODUCTS
    • SUPPLY DETAILS
    • FACT SHEETS
    • REFERENCES
    • GLOSSARY
  • INVESTORS
    • CALENDAR & REPORTS
    • COMPANY PRESENTATIONS
    • SHARE INFORMATION
    • DETAILED SHARE PRICE
    • SHARE PRICE CHART
    • SHARE PRICE CALCULATOR
    • ANALYST COVERAGE
    • INVESTOR CONTACTS
  • NEWS
    • PRESS RELEASES
    • REGULATORY NEWS
    • EMAIL ALERTS
    • EVENTS
  • CONTACT
    • CONTACT US
    • FAQs
    • CAREERS
    • LEGAL DISCLAIMER

Reports Archive

Protherics 20F 2007

Interim Report - Half year to 30 Sep 2007

Annual Report 2007
12 months to 31 March 2007

Interim result – Half year to 30 Sep 2006

Protherics 20F 2006


Annual Report 2006
12 months to 31 March 2006

Transition to IFRS
Supporting document for September 2005 Interim Statement

Interim Results - Half year to 30 Sep 2005

Protherics 20F 2005

Annual Report 2005
12 months to 31 March 2005

Interim Report - Half year to 30 Sep 2004

Annual Report 2004
12 months to 31 March 2004

Interim Report - Half year to 30 Sep 2003

Annual Report 2003
12 months to 31 March 2003

Interim Report - Half year to 30 Sep 2002

Annual Report 2002
12 months to 31 March 2002

Interim Report - Half year to 30 Sep 2001

Annual Report 2001
12 months to 31 March 2001

Link to Protherics' SEC filings

<< Back

Last Updated 25 July 2008 09:14